For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already ...
Individuals taking the drug saw a significant drop in these inflammatory cell clumps within just two weeks, and the reduction grew even stronger by week 12.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results